Related Experiment Video
Updated: Mar 15, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Personalised Nutrition in Obesity and Prediabetes: Do Genotypes Matter?
Magdalena Bossowska1, Filip Bossowski1, Edyta Adamska-Patruno2
1Department of Endocrinology, Diabetology and Internal Medicine, Medical University of Bialystok, 15-276 Białystok, Poland.
Gene-diet interactions influence obesity and prediabetes risk. Personalized nutrition combining general dietary advice with genotype-specific strategies offers the greatest risk reduction for high-risk individuals.
Area of Science:
- Nutrition Science
- Genetics
- Metabolic Health
Background:
- Obesity and prediabetes are significant global health challenges.
- Gene-diet interactions play a crucial role in cardiometabolic risk.
- Understanding these interactions is key to personalized prevention strategies.
Purpose of the Study:
- To systematically review evidence on gene-diet interactions in adults with obesity or prediabetes.
- To evaluate the impact of dietary patterns (Mediterranean, DASH), macronutrient quality, and energy restriction.
- To assess both single-variant and polygenic score approaches for gene-diet interactions.
Main Methods:
- Systematic literature search of PubMed for English language papers published within the last 5 years.
- Inclusion criteria required explicit statistical testing for gene-diet interactions and relevant cardiometabolic endpoints.
- Fewer than 200 studies were retained for analysis.
Main Results:
- General recommendations include restricting saturated fat and prioritizing carbohydrate quality, with significant genotype-dependent variations.
- Healthy dietary patterns showed reduced risk in individuals with high polygenic risk scores but limited benefit in low-risk groups.
- Specific gene variants (TCF7L2, APOA2) demonstrated genotype-specific responses to macronutrients and dietary antioxidants, impacting visceral adiposity and inflammation.
Conclusions:
- While some dietary changes (e.g., anti-inflammatory substitutions) benefit biomarkers universally, genotype-informed nutrition provides the most substantial risk reduction in high-risk populations.
- Clinical practice should integrate general dietary guidelines with targeted, genotype-specific nutritional strategies.
- Future research needs preregistered, genotype-stratified trials and locally trained polygenic scores to account for diverse ancestry and genetic architecture.
Related Concept Videos
Obesity
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Drug Dosing: Obese Patients
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

